-+ 0.00%
-+ 0.00%
-+ 0.00%

Jaguar Health Announces Plans To Use AI Platforms To Support Development, Commercialization, Healthcare Delivery Objectives For Crofelemer Programs To Treat Intestinal Failure

Benzinga·04/13/2026 12:39:54
Listen to the news

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that it plans to use AI platforms to enhance its development, commercialization, and healthcare delivery objectives for crofelemer programs for the treatment of intestinal failure in both adult and pediatric patients.